688314.SH
康拓医疗
SSE · Healthcare · Medical - Devices · CN
CNY 30.76
−5.03%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
19.2x
Market Cap
CNY 2.51B
MomentumView details →
1D Return
−5.03%
YTD Return
—
RSI (14)
43.7
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
19.2x
Market Cap
CNY 2.51B
RSI (14)
43.7
MomentumView details →
1D Return
−5.03%
YTD Return
—
Similar companies
Latest newsMore news →
Kangtuo Medical proposed a cash dividend of 1.5 yuan per 10 shares (tax inclusive), totaling 12.2442 million yuan.8d agoKangtuo Medical announced its H1 2026 results: net profit attributable to shareholders was 41.39 million yuan, down 24.74% year-on-year.8d agoKangtuo Medical's controlled subsidiary Xi'an Meiyan Tianshi Biotechnology Co., Ltd. obtained a Class III medical device registration certificate from China's National Medical Products Administration for injectable cross-linked sodium hyaluronate gel, used for correcting moderate-to-severe neck wrinkles, valid until August 23, 2031.10d ago